company background image
CDXC

ChromaDex NasdaqCM:CDXC Stock Report

Last Price

US$1.37

Market Cap

US$103.0m

7D

-6.8%

1Y

13.2%

Updated

24 Sep, 2023

Data

Company Financials +

ChromaDex Corporation

NasdaqCM:CDXC Stock Report

Mkt Cap: US$103.0m

CDXC Stock Overview

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products.

CDXC fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance0/6
Financial Health6/6
Dividends0/6

ChromaDex Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ChromaDex
Historical stock prices
Current Share PriceUS$1.37
52 Week HighUS$2.24
52 Week LowUS$1.15
Beta1.79
1 Month Change-8.67%
3 Month Change-13.29%
1 Year Change13.22%
3 Year Change-66.01%
5 Year Change-68.07%
Change since IPO-87.82%

Recent News & Updates

Market Cool On ChromaDex Corporation's (NASDAQ:CDXC) Revenues

Jun 08
Market Cool On ChromaDex Corporation's (NASDAQ:CDXC) Revenues

Recent updates

Market Cool On ChromaDex Corporation's (NASDAQ:CDXC) Revenues

Jun 08
Market Cool On ChromaDex Corporation's (NASDAQ:CDXC) Revenues

We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely

Mar 31
We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely

ChromaDex inks new commercial supply agreement for its Niagen ingredient with Nestlé

Oct 11

ChromaDex forms JV in Asia for Tru Niagen; plans to raise $3.1M via stock sale

Oct 03

ChromaDex in pact to introduce anti-aging compound in Brazil

Sep 01

Ayana Bio appoints Frank Jaksch as CEO

Aug 24

ChromaDex wins patent challenge as US regulator rejects Thorne Research's demand to invalidate patent

Aug 15

Some ChromaDex Corporation (NASDAQ:CDXC) Analysts Just Made A Major Cut To Next Year's Estimates

Mar 15
Some ChromaDex Corporation (NASDAQ:CDXC) Analysts Just Made A Major Cut To Next Year's Estimates

We're Not Very Worried About ChromaDex's (NASDAQ:CDXC) Cash Burn Rate

Mar 03
We're Not Very Worried About ChromaDex's (NASDAQ:CDXC) Cash Burn Rate

Companies Like ChromaDex (NASDAQ:CDXC) Can Afford To Invest In Growth

Nov 19
Companies Like ChromaDex (NASDAQ:CDXC) Can Afford To Invest In Growth

When Should You Buy ChromaDex Corporation (NASDAQ:CDXC)?

Sep 14
When Should You Buy ChromaDex Corporation (NASDAQ:CDXC)?

We Discuss Whether ChromaDex Corporation's (NASDAQ:CDXC) CEO Is Due For A Pay Rise

Jun 11
We Discuss Whether ChromaDex Corporation's (NASDAQ:CDXC) CEO Is Due For A Pay Rise

ChromaDex to sell Tru Niagen in 3,800 Walmart stores in the U.S.

Jun 07

Is There Now An Opportunity In ChromaDex Corporation (NASDAQ:CDXC)?

Jun 02
Is There Now An Opportunity In ChromaDex Corporation (NASDAQ:CDXC)?

We Think ChromaDex (NASDAQ:CDXC) Can Easily Afford To Drive Business Growth

May 14
We Think ChromaDex (NASDAQ:CDXC) Can Easily Afford To Drive Business Growth

ChromaDex Corporation 2021 Q1 - Results - Earnings Call Presentation

May 08

ChromaDex and Ro partner for Niagen supply

May 04

Calculating The Fair Value Of ChromaDex Corporation (NASDAQ:CDXC)

Apr 29
Calculating The Fair Value Of ChromaDex Corporation (NASDAQ:CDXC)

ChromaDex inks supply agreement for Niagen

Apr 28

ChromaDex Corporation (NASDAQ:CDXC): Is Breakeven Near?

Mar 22
ChromaDex Corporation (NASDAQ:CDXC): Is Breakeven Near?

Have Insiders Sold ChromaDex Corporation (NASDAQ:CDXC) Shares Recently?

Mar 04
Have Insiders Sold ChromaDex Corporation (NASDAQ:CDXC) Shares Recently?

At US$18.74, Is ChromaDex Corporation (NASDAQ:CDXC) Worth Looking At Closely?

Feb 26
At US$18.74, Is ChromaDex Corporation (NASDAQ:CDXC) Worth Looking At Closely?

Shareholder Returns

CDXCUS Life SciencesUS Market
7D-6.8%-3.9%-3.1%
1Y13.2%-2.9%15.1%

Return vs Industry: CDXC exceeded the US Life Sciences industry which returned -2.9% over the past year.

Return vs Market: CDXC underperformed the US Market which returned 15.1% over the past year.

Price Volatility

Is CDXC's price volatile compared to industry and market?
CDXC volatility
CDXC Average Weekly Movement6.1%
Life Sciences Industry Average Movement7.1%
Market Average Movement5.5%
10% most volatile stocks in US Market14.2%
10% least volatile stocks in US Market2.5%

Stable Share Price: CDXC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: CDXC's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1999113Rob Friedhttps://www.chromadex.com

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products.

ChromaDex Corporation Fundamentals Summary

How do ChromaDex's earnings and revenue compare to its market cap?
CDXC fundamental statistics
Market CapUS$103.02m
Earnings (TTM)-US$6.50m
Revenue (TTM)US$80.94m

1.3x

P/S Ratio

-15.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CDXC income statement (TTM)
RevenueUS$80.94m
Cost of RevenueUS$32.84m
Gross ProfitUS$48.10m
Other ExpensesUS$54.59m
Earnings-US$6.50m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.086
Gross Margin59.42%
Net Profit Margin-8.03%
Debt/Equity Ratio0%

How did CDXC perform over the long term?

See historical performance and comparison